Publications by authors named "Bob Anders"

Claim this Profile
T
The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate.
Barry E Gidal, Annie M Clark, Bob Anders, Frank Gilliam

Epilepsy Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
Steve S Chung, R Edward Hogan, Ilan Blatt, Balduin Lawson P, Huy Nguyen, Bob Anders

Epilepsy Behav· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes.
Annie M Clark, John M Pellock, Mary Holmay, Bob Anders, James Cloyd

Epilepsy Behav· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-daily extended-release topiramate (USL255): a subgroup analysis based on the level of treatment resistance.
R Edward Hogan, Ilan Blatt, Balduin Lawson, Venkatesh Nagaraddi, Toufic A Fakhoury, Bob Anders

Epilepsy Behav· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.
Steve S Chung, Toufic A Fakhoury, R Edward Hogan, Venkatesh N Nagaraddi, Ilan Blatt, Bob Anders

Epilepsia· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis